Skip to the page

Data / Drug companies / Patch, extended release

Companies that list patch, extended release products: 52 companies and 240 products in the FDA NDC directory

The FDA National Drug Code Directory lists 240 products that are patch, extended release products from 52 companies. The ten largest listers hold 43.8% of them, and the newest started marketing on September 1, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies
52
Products
240
Drugs by generic name
17
Main marketing category
Generic drugs (ANDA)

Companies that list patch, extended release products

Ranked by number of products in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Amneal Pharmaceuticals NY LLC16patch, extended releaseGeneric drugs (ANDA)June 11, 2025
Ingenus Pharmaceuticals, LLC14patch, extended releaseGeneric drugs (ANDA)February 11, 2025
Aveva Drug Delivery Systems Inc.13patch, extended releaseGeneric drugs (ANDA)February 11, 2025
Amneal Pharmaceuticals LLC10patch, extended releaseGeneric drugs (ANDA)September 30, 2020
Bryant Ranch Prepack10patch, extended releaseGeneric drugs (ANDA)November 1, 2024
Zydus Lifesciences Limited9patch, extended releaseGeneric drugs (ANDA)September 5, 2024
Zydus Pharmaceuticals USA Inc.9patch, extended releaseGeneric drugs (ANDA)September 5, 2024
Bryant Ranch Prepack8patch, extended releaseGeneric drugs (ANDA)December 19, 2019
Sandoz Inc8patch, extended releaseNew drug applications (NDA)July 6, 2007
Sandoz Inc8patch, extended releaseAuthorized generics (NDA)September 2, 2015
Amerisource Bergen7patch, extended releaseGeneric drugs (ANDA)July 1, 2026
SpecGx LLC7patch, extended releaseGeneric drugs (ANDA)May 6, 2020
BluePoint Laboratories6patch, extended releaseGeneric drugs (ANDA)May 28, 2026
Cardinal Health 110, LLC. DBA Leader6patch, extended releaseGeneric drugs (ANDA)March 20, 2026
Haleon US Holdings LLC6patch, extended releaseDrugs for further processingJune 1, 2022
Noven Therapeutics, LLC6patch, extended releaseNew drug applications (NDA)May 15, 2023
Ucb, Inc.6patch, extended releaseNew drug applications (NDA)April 2, 2012
Walgreen Company6patch, extended releaseNew drug applications (NDA)September 30, 2024
Knoa Pharma LLC5patch, extended releaseNew drug applications (NDA)February 14, 2011
Teva Pharmaceuticals USA, Inc.5patch, extended releaseGeneric drugs (ANDA)December 27, 2021
Alvogen Inc.4patch, extended releaseGeneric drugs (ANDA)May 17, 2022
Bryant Ranch Prepack4patch, extended releaseGeneric drugs (ANDA)November 1, 2024
A-S Medication Solutions3patch, extended releaseNew drug applications (NDA)September 5, 2024
Breckenridge Pharmaceutical, Inc.3patch, extended releaseGeneric drugs (ANDA)December 19, 2019
CVS Pharmacy3patch, extended releaseNew drug applications (NDA)August 6, 2015
Dr. Reddy's Laboratories Inc.3patch, extended releaseGeneric drugs (ANDA)February 10, 2024
Dr. Reddy's Laboratories Inc.3patch, extended releaseNew drug applications (NDA)May 14, 2015
Dr. Reddy's Laboratories Inc.3patch, extended releaseNew drug applications (NDA)July 13, 2018
Golden State Medical Supply, Inc.3patch, extended releaseNew drug applications (NDA)November 12, 1999
Haleon US Holdings LLC3patch, extended releaseNew drug applications (NDA)May 12, 2011
Novartis Pharmaceuticals Corporation3patch, extended releaseNew drug applications (NDA)July 6, 2007
Rite Aid Corporation3patch, extended releaseNew drug applications (NDA)May 14, 2015
Rugby Laboratories3patch, extended releaseNew drug applications (NDA)April 1, 2016
Strategic Sourcing Services LLC3patch, extended releaseNew drug applications (NDA)November 2, 2015
Target Corporation3patch, extended releaseNew drug applications (NDA)February 16, 2000
The Kroger Co.3patch, extended releaseNew drug applications (NDA)August 25, 2015
Topco Associates LLC3patch, extended releaseGeneric drugs (ANDA)June 25, 2024
Topco Associates LLC3patch, extended releaseNew drug applications (NDA)September 1, 2026
Wal-Mart Stores Inc3patch, extended releaseAuthorized generics (NDA)October 19, 2010
Chain Drug Marketing Association2patch, extended releaseNew drug applications (NDA)October 31, 2020
H E B2patch, extended releaseGeneric drugs (ANDA)June 25, 2024
NorthStar Rx LLC2patch, extended releaseGeneric drugs (ANDA)October 1, 2019
Baxter Healthcare Company1patch, extended releaseNew drug applications (NDA)December 1, 2016
Bershtel Enterprises1patch, extended releaseOver the counter monograph drugsDecember 1, 2015
Dolgencorp, Inc. (dollar General & Rexall)1patch, extended releaseNew drug applications (NDA)June 15, 2019
LTS Therapy Systems, LLC1patch, extended releaseGeneric drugs (ANDA)May 17, 2022
Lotfancy, Inc.1patch, extended releaseOver the counter monograph drugsJanuary 1, 2026
Mayne Pharma Inc.1patch, extended releaseGeneric drugs (ANDA)August 3, 2016
NuCare Pharmaceuticals,Inc.1patch, extended releaseGeneric drugs (ANDA)November 24, 2020
Padagis Israel Pharmaceuticals Ltd1patch, extended releaseGeneric drugs (ANDA)June 13, 2017
Rhodes Pharmaceuticals LLC1patch, extended releaseGeneric drugs (ANDA)November 1, 2024
Sam's West Inc1patch, extended releaseNew drug applications (NDA)March 2, 2012

Drugs most often listed

DrugProducts hereCompanies listing it
Menthol1263
Lidocaine1216
Estradiol4553
Nicotine4837
Buprenorphine3024
Scopolamine1212
Rivastigmine2811
Nicotine transdermal system1810
Clonidine49
Fentanyl164
Dextroamphetamine43
Nicotine transdermal system patch62
Scolopamine transdermal system42
Scopolamine transdermal system22
Fentanyl transdermal71
Rotigotine61
Estradiol/norethindrone acetate transdermal system21

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.